Collegium Pharmaceutical
COLL
COLL
138 hedge funds and large institutions have $745M invested in Collegium Pharmaceutical in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 54 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
1% less funds holding
Funds holding: 140 → 138 (-2)
26% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 54
Holders
138
Holding in Top 10
1
Calls
$1.85M
Puts
$1.7M
Top Buyers
| 1 | +$8.44M | |
| 2 | +$7.5M | |
| 3 | +$4.78M | |
| 4 |
Millennium Management
New York
|
+$3.3M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$2.82M |
Top Sellers
| 1 | -$8.65M | |
| 2 | -$8.22M | |
| 3 | -$3.75M | |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$2.78M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$2.41M |